Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis (NCT02037347)Brett King2010-10-01
FLT-PET Imaging of Brain Tumors in Children (NCT01244737)Frederick Daniel Grant2010-10-01
Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-damaged Skin (NCT01214577)Peplin2010-10-01
Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy (NCT01175928)NormaTec Industries LP2010-10-01
Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT01039207)Gynecologic Oncology Group2010-10-01
Trial of Steroids in Pediatric Acute Lung Injury/ARDS (NCT01274260)University of Tennessee2010-10-01
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer (NCT01008150)NSABP Foundation Inc2010-10-01
HIV/AIDS, Severe Mental Illness and Homelessness (NCT01172704)Boston Medical Center2010-10-01
Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery (NCT01234532)University of Maryland, Baltimore2010-10-01
ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients (NCT01304693)Alcon Research2010-10-01
Ph IIA Study (SOC +/- NS5B) (NCT01193361)Bristol-Myers Squibb2010-10-01
The Paracetamol AfteR Traumatic Brain InjurY Study (NCT01231139)Dr. M.K. Saxena2010-10-01
Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program (NCT01477190)McGill University Health Centre/Research Institute of the McGill University Health Centre2010-10-01
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia (NCT01111292)National Cancer Institute (NCI)2010-10-01
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. (NCT01124864)Novartis Pharmaceuticals2010-10-01
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma (NCT01201915)Genentech, Inc.2010-10-01
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer (NCT01217411)National Cancer Institute (NCI)2010-10-01
Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation (NCT01225211)Vertex Pharmaceuticals Incorporated2010-10-01
Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention (NCT01308125)Miracor Medical SA2010-10-01
Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD (NCT01210560)Otsuka Pharmaceutical Development & Commercialization, Inc.2010-10-01
Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2) (NCT01588756)Assistance Publique - Hôpitaux de Paris2010-10-01
The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01205269)AstraZeneca2010-10-01
Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis (NCT01261624)Italfarmaco2010-10-01
TREatment of degeNerative and Neoplastic Diseases With Rituximab (NCT01277172)Probiomed S.A. de C.V.2010-10-01
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP (NCT01210287)Fudan University2010-10-01
Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol (NCT01362218)Ferrer Internacional S.A.2010-10-01
Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) (NCT01303224)Menarini Group2010-10-01
Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG) (NCT01271322)National Center for Tumor Diseases, Heidelberg2010-10-01
Promotora-based Latino Family CVD Risk Reduction (NCT01714271)University of California, Los Angeles2010-10-01
A Randomized, Placebo-controlled Study Investigating the Effects of Moxaverine on Ocular Blood Flow After Oral Administration in Healthy Subjects (NCT01629680)Medical University of Vienna2010-10-01
Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (NCT01234766)Dartmouth-Hitchcock Medical Center2010-10-01
Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder (NCT01222676)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2010-10-01
Melatonin in Relapsing-Remitting Multiple Sclerosis Patients (NCT01279876)Tehran University of Medical Sciences2010-10-01
Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia (NCT01222143)University Health Network, Toronto2010-10-01
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes (NCT01236573)National Institutes of Health Clinical Center (CC)2010-10-01
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer (NCT01299038)Beth Israel Deaconess Medical Center2010-10-01
A Safety and Effectiveness Pilot Study of PRF-108 and PRF-110 in Healthy Volunteers (NCT00883194)PainReform LTD2010-10-01
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus (NCT01211470)PolyMedix, Inc.2010-10-01
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults (NCT01227330)University of Missouri-Columbia2010-10-01
Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide (NCT01092559)Geno LLC2010-10-01
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^ (NCT01227980)National Institute on Alcohol Abuse and Alcoholism (NIAAA)2010-10-01
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001) (NCT01215851)Global Alliance for TB Drug Development2010-10-01
A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer (NCT01188707)Herlev Hospital2010-10-01
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) (NCT01221298)AbbVie (prior sponsor, Abbott)2010-10-01
Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent. (NCT02166320)Karolinska University Hospital2010-10-01
Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris (NCT01245946)Pontificia Universidad Catolica de Chile2010-10-01
Immune-Pineal Axis Function in Chronic Tension-Type Headache (NCT01954277)Hospital de Clinicas de Porto Alegre2010-10-01
A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock (NCT01145560)AstraZeneca2010-10-01
Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103) (NCT02101957)University Hospital, Angers2010-10-01
Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury (NCT00810940)Abela Pharmaceuticals, Inc.2010-10-01
Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) (NCT01254539)Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia2010-10-01
Robotic Locomotor Experience Applied to Parkinson's Disease (NCT01302184)Azienda Ospedaliero Universitaria Maggiore della Carita2010-10-01
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery (NCT01206140)National Cancer Institute (NCI)2010-10-01
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis (NCT01214564)Peplin2010-10-01
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II (NCT01183455)National Institute of Allergy and Infectious Diseases (NIAID)2010-10-01
Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (NCT01416155)Biogen2010-10-01
Therapeutic Effects of Neurofeedback in Anorexia Nervosa (NCT01390493)Medical University of Graz2010-10-01
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus (NCT01069965)N-Gene Research Laboratories, Inc.2010-10-01
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI (NCT01322815)Georgetown University2010-10-01
Curcumin in Treating Patients With Familial Adenomatous Polyposis (NCT00641147)National Cancer Institute (NCI)2010-10-01
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients (NCT01197794)AstraZeneca2010-10-01
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors (NCT01188499)TetraLogic Pharmaceuticals2010-10-01
Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy (NCT01239758)Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2010-10-01
Use of Pulsed Electromagnetic Fields for Postoperative Knee Pain (NCT01415856)Center for Joint Surgery and Sports Medicine, Maryland2010-10-01
Study of NGX-1998 for the Treatment of Postherpetic Neuralgia (NCT01228838)NeurogesX2010-10-01
Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD (NCT01209715)University of Miami2010-10-01
Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA) (NCT01620554)Bioprojet2010-10-01
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy (NCT01240759)Shionogi2010-10-01
OCT Evaluation of Healing of COMBO Stent (NCT01274234)Prof. Stephen Lee2010-10-01
Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. (NCT01231438)Helse Stavanger HF2010-10-01
Perimenopausal Estrogen Replacement Therapy Study (NCT01308814)University of North Carolina, Chapel Hill2010-10-01
Vercise Implantable Stimulator for Treating Parkinson's Disease (NCT01221948)Boston Scientific Corporation2010-10-01
An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia (NCT01175135)Pfizer2010-10-01
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) (NCT01207687)National Cancer Institute (NCI)2010-10-01
Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma (NCT01147393)Weill Medical College of Cornell University2010-10-01
Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma (NCT01342627)Centro di Riferimento Oncologico - Aviano2010-10-01
Trimodality Management of T1b Esophageal Cancers (NCT01217060)M.D. Anderson Cancer Center2010-10-01
Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy (NCT01003236)Shiraz University of Medical Sciences2010-10-01
Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA) (NCT01264211)TRB Chemedica2010-10-01
A Study of LY900010 in Erectile Dysfunction (NCT01160289)Eli Lilly and Company2010-10-01
Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma (NCT01026051)Mannkind Corporation2010-10-01
Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study (NCT01255527)Yonsei University2010-10-01
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes (NCT00947427)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2010-10-01
Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) (NCT01216371)Association of Urologic Oncology (AUO)2010-10-01
Oxidative Stress and Nutritional Supplementation Intervention Study (NCT01234506)University of Saskatchewan2010-10-01
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib (NCT01217034)Kindai University2010-10-01
AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01253447)National Cancer Institute (NCI)2010-10-01
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis (NCT01455246)University of Padova2010-10-01
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age (NCT01193920)Novartis Vaccines2010-10-01
Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection (NCT01213966)Medicines for Malaria Venture2010-10-01
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis (NCT01223664)Sun Yat-sen University2010-10-01
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury (NCT01225055)Thomas J. Schnitzer2010-10-01
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer (NCT01924078)Fudan University2010-10-01
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors (NCT01105130)Wake Forest University Health Sciences2010-10-01
Study to Assess the Safety and Efficacy of Multiple Doses of VB-201 on Biomarkers (NCT01159730)Vascular Biogenics Ltd. operating as VBL Therapeutics2010-10-01
Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status (NCT02898012)Assistance Publique - Hôpitaux de Paris2010-10-01
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome (NCT01156909)Haukeland University Hospital2010-10-01
ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction (NCT01234324)AIO-Studien-gGmbH2010-10-01
Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin (NCT01226992)University Health Network, Toronto2010-10-01
Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina (NCT01214499)Fundación de Investigación Biomédica - Hospital Universitario de La Princesa2010-10-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.